体重指数对影响生活质量的慢性髂股静脉阻塞初始表现及支架置入后结局的影响
该回顾性研究纳入464例因影响生活质量的慢性髂股静脉阻塞行IVUS引导下支架置入的患者,按BMI<30或≥30分组。肥胖组髂股静脉狭窄程度较轻但静脉高压更重、小腿泵功能更好;支架置入后两组临床、支架通畅率及生活质量结局无差异。
要点
- 肥胖患者髂股静脉狭窄程度较轻但静脉高压更重、小腿泵功能更好
- 支架置入后两组临床改善、支架通畅率及生活质量结局无显著差异
- BMI不影响IVUS引导下支架置入的临床或支架相关结局
核心结论
- 肥胖的慢性髂股静脉阻塞患者髂股静脉狭窄程度较轻、静脉高压更重、小腿泵功能更好,支架置入后临床、支架通畅率及生活质量结局与非肥胖者无差异。
研究设计与样本
- 回顾性分析464例连续患者(464条肢体)因影响生活质量的慢性髂股静脉阻塞行初始髂股静脉支架置入(2014-2017年)的电子病历数据。
- 按BMI<30 kg/m2(组I,122条肢体)和BMI≥30 kg/m2(组II,342条肢体)分组比较。
- 中位随访22个月,采用Kaplan-Meier分析评估支架通畅率。
主要发现
- 组I中位BMI为26.3 kg/m2(四分位距19.6-29.9 kg/m2),组II为38.9 kg/m2(四分位距30.0-66.9 kg/m2)。
- IVUS管腔面积确定的压迫程度在髂总、髂外及股总段组I均高于组II(P < .01)。
- 仰卧位足静脉及股静脉压力组II高于组I(P < .001)。
- 射血分数组II高于组I(57.4% vs 45.6%;P = .0008),残余容积分数组II低于组I(27.5% vs 40.5%;P = .0008)。
- 基线VCSS和GOS组I低于组II(P < .05),但VAS疼痛评分或溃疡患病率无差异。
临床怎么用
- 对于肥胖的慢性髂股静脉阻塞患者,IVUS引导下支架置入可获得与非肥胖患者相似的临床、支架通畅率及生活质量结局。
- 肥胖患者静脉高压更重但狭窄程度较轻,评估时需结合血流动力学而非仅依赖形态学狭窄程度。
局限性
- 回顾性研究设计。
- 单中心数据,样本来自2014-2017年连续患者。
- 中位随访22个月,5年通畅率数据可能不完整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The incidence of obesity has been increasing, with recent data indicating that the age-adjusted mean body mass index (BMI) is close to 30 kg/m2 in the United States. Prior studies have raised concerns for an increased incidence of chronic venous insufficiency in the obese population. We aimed to build on current knowledge by assessing the effects of BMI on the initial presentation and outcomes after intravascular ultrasound (IVUS) luminal area-guided stenting in patients presenting with quality of life (QOL)-impairing chronic iliofemoral venous obstruction (CIVO). METHODS: A retrospective analysis of contemporaneously entered electronic medical record data on 464 continuous patients (464 limbs) with initial iliofemoral stents (2014-2017) for QOL-impairing CIVO was performed. The characteristics evaluated and compared included the degree of iliofemoral compression, CEAP (clinical, etiologic, anatomic, pathophysiologic) clinical class, venous clinical severity score (VCSS), grade of swelling (GOS), visual analog scale (VAS) for pain score, ulcer healing, reflux (venous segmental disease score; venous filling index-90), calf pump function (ejection fraction; residual volume fraction), and quality of life (CIVIQ-20 [chronic lower limb venous insufficiency 20-item questionnaire]) for those with a BMI <30 kg/m2 (group I) and a BMI ≥30 kg/m2 (group II). Paired and unpaired t tests were used for comparisons of the clinical variables and a Kaplan-Meier analysis was used to evaluate stent patency. RESULTS: Of the 464 limbs in the study cohort, 122 were in group I and 342 in group II. The median BMI was 26.3 kg/m2 (interquartile range, 19.6-29.9 kg/m2) in group I and 38.9 kg/m2 (interquartile range, 30.0-66.9 kg/m2) in group II. The IVUS luminal area-determined degree of compression was higher in group I than in group II across the common iliac, external iliac, and common femoral segments (P < .01). The supine foot venous and femoral venous pressures were higher in group II than in group I (P < .001). The ejection fraction was higher (57.4% vs 45.6%; P = .0008) and residual volume fraction was lower (27.5% vs 40.5%; P = .0008) in group II than in group I. Although the baseline VCSS and GOS were lower in group I than in group II (P < .05), no differences were found in the VAS for pain scores or ulcer prevalence. The median follow-up was 22 months. At 24 months after stenting, improvement was found in the VCSS, GOS, and VAS for pain score in both groups. The CIVIQ-20 QOL score had improved from 58.1 to 18.8 in group I (P = .0002) and from 60 to 37.5 in group II (P < .0001). At 5 years, primary patency was 70% in group I and 73% in group II (P = .6) and primary assisted patency was 100% in both groups (P = .99) without a significant difference in the reintervention rate (P = .5). CONCLUSIONS: Obese patients with CIVO-impairing QOL have a lesser degree of iliofemoral venous stenosis, more severe venous hypertension, and better calf pump function than their nonobese counterparts. After stenting, no differences were found in the clinical, stent patency, or QOL-related outcomes between the two groups.
引用
- Jayaraj A, Powell T, Raju S, et al. Effect of body mass index on initial presentation and outcomes after stenting for quality of life-impairing chronic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34358674. doi:10.1016/j.jvsv.2021.07.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。